Blog: SOMALOGIC, INC. : Regulation FD Disclosure, Financial Statements and Exhibits (form 8-K) – marketscreener.com

Item 7.01 Regulation FD Disclosure.

On January 11, 2022, SomaLogic, Inc. (the “Company”) issued a press release
providing a business update on its estimated year-end revenue results for its
fiscal year ending December 31, 2021, which it will discuss during its virtual
presentation at the annual J.P. Morgan Healthcare Conference on January 11, 2022
at 8:15 a.m. Eastern Time. The Company’s press release is attached as Exhibit
99.1 to this Current Report on Form 8-K and incorporated by reference herein. A
live audio webcast of the presentation along with a copy of the Company
presentation materials from the conference will be available through the
investor page at the Company’s website: investors.somalogic.com.

The information in this Item 7.01 of this Current Report on Form 8-K and the
exhibit hereto shall not be deemed “filed” for purposes of Section 18 of the
Securities Exchange Act of 1934 (the “Exchange Act”) or otherwise subject to the
liabilities of that section, nor shall it be deemed incorporated by reference in
any filing under the Securities Act of 1933, as amended, or the Exchange Act,
regardless of any general incorporation by reference language in such filing.

The Company’s actual results may differ materially from the preliminary
information provided in the accompanying press release. Factors that could cause
these preliminary estimates to differ include, but are not limited to, discovery
of new information that alters expectations about such results or impacts
valuation methodologies underlying such results.

This Current Report on Form 8-K and the accompanying press release contain
certain forward-looking statements within the meaning of the federal securities
laws, including statements relating to the expected future performance of the
Company. These forward-looking statements, including the Company’s 2021 revenue
outlook, are not historical and generally are identified by the words “believe,”
“project,” “expect,” “anticipate,” “estimate,” “intend,” “strategy,” “future,”
“opportunity,” “plan,” “may,” “should,” “will,” “would,” “will be,” “will
continue,” “will likely result,” and similar expressions that relate to the
Company’s strategy, expectations, plans, or intentions. All statements the
Company makes relating to its estimated and projected financial results or to
its expectations regarding future trends are forward-looking statements. In
addition, the Company, through its senior management team, from time to time
makes forward-looking public statements concerning its expected future
operations and performance and other developments. Forward-looking statements
are predictions, projections and other statements about future events that are
based on current expectations and assumptions and, as a result, are subject to
risks and uncertainties. Forward looking statements do not guarantee future
performance and involve known and unknown risks, uncertainties and other
factors. Many factors could cause actual results and events to differ
materially from the forward-looking statements in this press release, including
factors which are beyond the Company’s control. Investors should carefully
consider the risks and uncertainties described in the “Risk Factors” section of
the Proxy Statement/Prospectus filed with the Securities and Exchange Commission
(the “SEC”) on August 12, 2021 and the Company’s Current Report on Form 8-K
filed with the SEC on September 8, 2021, as well as subsequent annual and
periodic reports filed with the Securities and Exchange Commission. These
filings identify and address important risks and uncertainties that could cause
actual events and results to differ materially from those contained in the
forward-looking statements. All forward-looking information and subsequent
written and oral forward-looking statements attributable to the Company, or to
persons acting on its behalf, are expressly qualified in their entirety by the
cautionary statements. Forward-looking statements speak only as of the date they
are made. Readers are cautioned not to put undue reliance on forward-looking
statements, and the Company assumes no obligation and does not intend to update
or revise these forward-looking statements, whether as a result of new
information, future events, or otherwise. The Company does not give any
assurance that it will achieve its expectations.

Item 9.01. Financial Statements and Exhibits.



Exhibit
Number    Exhibit Description
99.1        Press Release issued by SomaLogic, Inc. on January 11, 2022
104       Cover Page Interactive Data File (embedded within the Inline XBRL document)




                                       1

© Edgar Online, source Glimpses

Leave a Reply

Fill in your details below or click an icon to log in:

WordPress.com Logo

You are commenting using your WordPress.com account. Log Out /  Change )

Google photo

You are commenting using your Google account. Log Out /  Change )

Twitter picture

You are commenting using your Twitter account. Log Out /  Change )

Facebook photo

You are commenting using your Facebook account. Log Out /  Change )

Connecting to %s